{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T15:52:39Z","timestamp":1790783559622,"version":"4.1.0"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2020,12,31]],"date-time":"2020-12-31T00:00:00Z","timestamp":1609372800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,12,31]],"date-time":"2020-12-31T00:00:00Z","timestamp":1609372800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"The International Society for Clinical Electrophysiology and Vision"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Doc Ophthalmol"],"published-print":{"date-parts":[[2021,6]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Purpose<\/jats:title>\n                <jats:p>To review the evidence on the usefulness of the multifocal visual evoked potential (mfVEP) test in patients with optic neuritis (ON) and\/or multiple sclerosis (MS).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>We critically review key published evidence on the use of mfVEP in ON\/MS patients and its association with other functional and structural tests.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Multifocal VEP tests are useful in detecting abnormality in patients with ON\/MS and monitor the progression of lesions (remyelination, atrophy). In addition, mfVEP has good correlation with conventional visual evoked potential (VEP), standard automated perimetry, optical coherence tomography and magnetic resonance imaging. In patients with ON, mfVEP might be useful in predicting the risk of conversion to MS.\n<\/jats:p>\n              <\/jats:sec>","DOI":"10.1007\/s10633-020-09799-4","type":"journal-article","created":{"date-parts":[[2020,12,31]],"date-time":"2020-12-31T03:02:36Z","timestamp":1609383756000},"page":"283-292","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["The contribution of multifocal visual evoked potentials in patients with optic neuritis and multiple sclerosis: a review"],"prefix":"10.1007","volume":"142","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9390-7733","authenticated-orcid":false,"given":"Paraskevas","family":"Zafeiropoulos","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Katsanos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George","family":"Kitsos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Stefaniotou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ioannis","family":"Asproudis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,12,31]]},"reference":[{"issue":"391","key":"9799_CR1","doi-asserted-by":"publisher","first-page":"1622","DOI":"10.1016\/S0140-6736(18)30481-1","volume":"21","author":"AJ Thompson","year":"2018","unstructured":"Thompson AJ, Baranzini SE, Geurts J, Hemmer B, Ciccarelli O (2018) Multiple sclerosis. Lancet 21(391):1622\u20131636","journal-title":"Lancet"},{"key":"9799_CR2","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/S1474-4422(13)70259-X","volume":"13","author":"AT Toosy","year":"2014","unstructured":"Toosy AT, Mason DF, Miller DH (2014) Optic neuritis. Lancet Neurol 13:83\u201399","journal-title":"Lancet Neurol"},{"issue":"10","key":"9799_CR3","doi-asserted-by":"publisher","first-page":"2061","DOI":"10.3390\/ijms18102061","volume":"18","author":"P Schwenkenbecher","year":"2017","unstructured":"Schwenkenbecher P, Sarikidi A, B\u00f6nig L, Wurster U, Bronzlik P, S\u00fchs KW, Pul R, Stangel M, Skripuletz T (2017) Clinically isolated syndrome according to McDonald 2010: intrathecal IgG synthesis still predictive for conversion to multiple sclerosis. Int J Mol Sci 18(10):2061","journal-title":"Int J Mol Sci"},{"key":"9799_CR4","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1212\/01.WNL.0000082654.99838.EF","volume":"61","author":"EM Frohman","year":"2003","unstructured":"Frohman EM, Goodin DS, Calabresi PA et al (2003) The utility of MRI in suspected MS: report of the therapeutics and technology assessment subcommittee of the American Academy of Neurology. Neurology 61:602\u2013611","journal-title":"Neurology"},{"key":"9799_CR5","doi-asserted-by":"publisher","first-page":"3758","DOI":"10.1167\/iovs.14-14571","volume":"55","author":"D Alshowaeir","year":"2014","unstructured":"Alshowaeir D, Yiannikas C, Garrick R, Parratt J, Barnett MH, Graham SL, Klistorner A (2014) Latency of multifocal visual evoked potentials in nonoptic neuritis eyes of multiple sclerosis patients associated with optic radiation lesions. Invest Ophthalmol Vis Sci 55:3758\u20133764","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"9799_CR6","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/S1350-9462(02)00061-7","volume":"22","author":"DC Hood","year":"2003","unstructured":"Hood DC, Greenstein VC (2003) Multifocal VEP and ganglion cell damage: applications and limitations for the study of glaucoma. Prog Retin Eye Res 22:201\u2013251","journal-title":"Prog Retin Eye Res"},{"key":"9799_CR7","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/0013-4694(94)90114-7","volume":"90","author":"HA Baseler","year":"1994","unstructured":"Baseler HA, Sutter EE, Klein SA, Carney T (1994) The topography of visual evoked response properties across the visual field. Electroencephalogr Clin Neurophysiol 90:65\u201381","journal-title":"Electroencephalogr Clin Neurophysiol"},{"key":"9799_CR8","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1177\/1352458509359782","volume":"16","author":"M Laron","year":"2010","unstructured":"Laron M, Cheng H, Zhang B, Schiffman JS, Tang RA, Frishman LJ (2010) Comparison of multifocal visual evoked potential, standard automated perimetry and optical coherence tomography in assessing visual pathway in multiple sclerosis patients. Mult Scler 16:412\u2013426","journal-title":"Mult Scler"},{"key":"9799_CR9","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1097\/00041327-200312000-00010","volume":"23","author":"DC Hood","year":"2003","unstructured":"Hood DC, Odel JG, Winn BJ (2003) The multifocal visual evoked potentials. J Neuro-Ophthalmol 23:279\u2013289","journal-title":"J Neuro-Ophthalmol"},{"key":"9799_CR10","doi-asserted-by":"publisher","first-page":"1234","DOI":"10.1016\/j.clinph.2017.03.047","volume":"128","author":"G Pihl-Jensen","year":"2017","unstructured":"Pihl-Jensen G, Schmidt MF, Frederiksen JL (2017) Multifocal visual evoked potentials in optic neuritis and multiple sclerosis: a review. Clin Neurophysiol 128:1234\u20131245","journal-title":"Clin Neurophysiol"},{"key":"9799_CR11","doi-asserted-by":"publisher","first-page":"1574","DOI":"10.1016\/j.clinph.2015.09.129","volume":"127","author":"L De Santiago","year":"2016","unstructured":"De Santiago L, Ortiz del Castillo M, Blanco R, Barea R, Rodr\u00edguez-Ascariz JM, Miguel Jim\u00e9nez JM, S\u00e1nchez-Morla EM, Boquete L (2016) A signal-to-noise-ratio-based analysis of multifocal visual-evoked potentials in multiple sclerosis risk assessment. Clin Neurophysiol 127:1574\u20131580","journal-title":"Clin Neurophysiol"},{"key":"9799_CR12","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1007\/s10633-014-9467-5","volume":"130","author":"D Narayanan","year":"2015","unstructured":"Narayanan D, Cheng H, Tang RA, Freshman LJ (2015) Reproducibility of multifocal visual evoked potential and traditional visual evoked potential in normal and multiple sclerosis eyes. Doc Ophthalmol 130:31\u201341","journal-title":"Doc Ophthalmol"},{"key":"9799_CR13","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1007\/s40263-018-0575-8","volume":"32","author":"A Klistorner","year":"2018","unstructured":"Klistorner A, Chai Y, Leocani L, Albrecht P, Aktas O, Butzkueven H, Ziemssen T, Ziemssen F, Frederiksen J, Xu L, Cadavid D, RENEW MF-VEP (2018) Assessment of opicinumab in acute optic neuritis using multifocal visual evoked potential. CNS Drugs 32:1159\u20131171","journal-title":"CNS Drugs"},{"key":"9799_CR14","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1097\/00061198-200604000-00010","volume":"15","author":"B Fortune","year":"2006","unstructured":"Fortune B, Demirel S, Zhang X, Hood DC, Johnson CA (2006) Repeatability of normal multifocal VEP: implications for detecting progression. J Glaucoma 15:131\u2013141","journal-title":"J Glaucoma"},{"key":"9799_CR15","doi-asserted-by":"publisher","first-page":"323.e1","DOI":"10.1016\/j.ophtha.2005.10.017","volume":"113","author":"CL Fraser","year":"2006","unstructured":"Fraser CL, Klistorner A, Graham SL, Garrick R, Billson FA, Grigg JR (2006) Multifocal visual evoked potential analysis of inflammatory or demyelinating optic neuritis. Ophthalmology 113:323.e1\u2013323.e2","journal-title":"Ophthalmology"},{"key":"9799_CR16","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1001\/archneur.63.6.847","volume":"63","author":"C Fraser","year":"2006","unstructured":"Fraser C, Klistorner A, Graham S, Garrick R, Billson F, Grigg J (2006) Multifocal visual evoked potential latency analysis: predicting progression to multiple sclerosis. Arch Neurol 63:847\u2013850","journal-title":"Arch Neurol"},{"key":"9799_CR17","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1111\/j.1442-9071.2006.01277.x","volume":"34","author":"N Pakrou","year":"2006","unstructured":"Pakrou N, Casson R, Kaines A, Selva D (2006) Multifocal objective perimetry compared with Humphrey full-threshold perimetry in patients with optic neuritis. Clin Exp Ophthalmol 34:562\u2013567","journal-title":"Clin Exp Ophthalmol"},{"key":"9799_CR18","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1007\/s10633-007-9112-7","volume":"117","author":"LK Grover","year":"2008","unstructured":"Grover LK, Hood DC, Ghadiali Q, Grippo TM, Wenick AS, Greenstein VC, Behrens MM, Odel JG (2008) A comparison of multifocal and conventional visual evoked potential techniques in patients with optic neuritis\/multiple sclerosis. Doc Ophthalmol 117:121\u2013128","journal-title":"Doc Ophthalmol"},{"key":"9799_CR19","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1007\/s10633-007-9072-y","volume":"116","author":"A Klistorner","year":"2008","unstructured":"Klistorner A, Fraser C, Garrick R, Graham S, Arvind H (2008) Correlation between full-field and multifocal VEPs in optic neuritis. Doc Ophthalmol 116:19\u201327","journal-title":"Doc Ophthalmol"},{"key":"9799_CR20","doi-asserted-by":"publisher","first-page":"928","DOI":"10.1177\/1352458509105228","volume":"15","author":"A Klistorner","year":"2009","unstructured":"Klistorner A, Arvind H, Nguyen T, Garric R, Paine M, Graham S, Yiannikas C (2009) Fellow eye changes in optic neuritis correlate with the risk of multiple sclerosis. Mult Scler 15:928\u2013932","journal-title":"Mult Scler"},{"key":"9799_CR21","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1007\/s10633-008-9147-4","volume":"118","author":"A Klistorner","year":"2009","unstructured":"Klistorner A, Arvind H, Nguyen T, Garrick R, Paine M, Graham S, O\u2019Day J, Yannikas C (2009) Multifocal VEP and OCT in optic neuritis: a topographical study of the structure-function relationship. Doc Ophthalmol 118:129\u2013137","journal-title":"Doc Ophthalmol"},{"key":"9799_CR22","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1177\/1352458513493683","volume":"20","author":"R Blanco","year":"2014","unstructured":"Blanco R, P\u00e9rez-Rico C, Puertas-Mu\u00f1oz I, Ayuso-Peralta L, Boquete L, Ar\u00e9valo-Serrano J (2014) Functional assessment of the visual pathway with multifocal visual evoked potentials, and their relationship with disability in patients with multiple sclerosis. Mult Scler 20:183\u2013191","journal-title":"Mult Scler"},{"key":"9799_CR23","doi-asserted-by":"publisher","first-page":"6127","DOI":"10.1167\/iovs.14-14807","volume":"55","author":"C P\u00e9rez-Rico","year":"2014","unstructured":"P\u00e9rez-Rico C, Ayuso-Peralta L, Rubio-P\u00e9rez L, Rold\u00e1n-D\u00edaz I, Ar\u00e9valo-Serrano J, Jim\u00e9nez-Jurado D, Blanco R (2014) Evaluation of visual structural and functional factors that predict the development of multiple sclerosis in clinically isolated syndrome patients. Invest Ophthalmol Vis Sci 55:6127\u20136131","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"9799_CR24","doi-asserted-by":"publisher","first-page":"e102546","DOI":"10.1371\/journal.pone.0102546","volume":"9","author":"P Sriram","year":"2014","unstructured":"Sriram P, Wang C, Yiannikas C, Garrick R, Barnett M, Parrat J, Graham S, Arvind H, Klistorner A (2014) Relationship between optical coherence tomography and electrophysiology of the visual pathway in non-optic neuritis eyes of multiple sclerosis patients. PLoS ONE 9:e102546","journal-title":"PLoS ONE"},{"key":"9799_CR25","doi-asserted-by":"publisher","first-page":"1617","DOI":"10.1016\/j.clinph.2014.11.010","volume":"126","author":"D Alshowaeir","year":"2015","unstructured":"Alshowaeir D, Yannikas C, Garrick R, Van Der Walt A, Graham SL, Fraser C, Klistomer A (2015) Multifocal VEP assessment of optic neuritis evolution. Clin Neurophysiol 126:1617\u20131623","journal-title":"Clin Neurophysiol"},{"key":"9799_CR26","doi-asserted-by":"publisher","first-page":"e0121084","DOI":"10.1371\/journal.pone.0121084","volume":"10","author":"A van der Walt","year":"2015","unstructured":"van der Walt A, Kolbe S, Mitchell P, Wang Y, Butzkueven H, Egan G, Yiannikas C, Graham S, Kilpatrick T, Klistorner A (2015) Parallel changes in structural and functional measures of optic nerve myelination after optic neuritis. PLoS ONE 10:e0121084","journal-title":"PLoS ONE"},{"issue":"3","key":"9799_CR27","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1016\/j.ophtha.2018.06.022","volume":"126","author":"T Shen","year":"2019","unstructured":"Shen T, You Y, Arunachalam S, Fontes A, Liu S, Gupta V, Parratt J, Wang C, Barnett M, Barton J, Chitranshi N, Zhu L, Fraser CL, Graham SL, Klistorner A, Yiannikas C (2019) Differing structural and functional patterns of optic nerve damage in multiple sclerosis and neuromyelitis optica spectrum disorder. Ophthalmology 126(3):445\u2013453","journal-title":"Ophthalmology"},{"issue":"1","key":"9799_CR28","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1016\/j.clinph.2018.10.007","volume":"130","author":"D Narayanan","year":"2019","unstructured":"Narayanan D, Cheng H, Tang RA, Frishman LJ (2019) Multifocal visual evoked potentials and contrast sensitivity correlate with ganglion cell-inner plexiform layer thickness in multiple sclerosis. Clin Neurophysiol 130(1):180\u2013188","journal-title":"Clin Neurophysiol"},{"key":"9799_CR29","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/S1474-4422(16)30377-5","volume":"16","author":"D Cadavid","year":"2017","unstructured":"Cadavid D, Balcer L, Galetta S, Aktas O, Ziemssen T, Vanopden-Bosch L, RENEW Study Investigators et al (2017) Safety and efficacy of opicinumab in acute optic neuritis (RENEW): a randomised, placebo-controlled, phase 2 trial. Lancet Neurol 16:189\u2013199","journal-title":"Lancet Neurol"}],"container-title":["Documenta Ophthalmologica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10633-020-09799-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10633-020-09799-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10633-020-09799-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,12]],"date-time":"2021-05-12T06:40:10Z","timestamp":1620801610000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10633-020-09799-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12,31]]},"references-count":29,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,6]]}},"alternative-id":["9799"],"URL":"https:\/\/doi.org\/10.1007\/s10633-020-09799-4","relation":{},"ISSN":["0012-4486","1573-2622"],"issn-type":[{"value":"0012-4486","type":"print"},{"value":"1573-2622","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,12,31]]},"assertion":[{"value":"17 April 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 October 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 December 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 March 2021","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Update","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Open access funding statement is removed.","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"This article does not contain any studies with human participants or animals performed by any of the authors.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Statement of human rights"}},{"value":"Authors Paraskevas Zafeiropoulos, George Kitsos, Maria Stefaniotou and Ioannis Asproudis declare that they have no conflict of interest. Andreas Katsanos declares honoraria and congress expenses by Santen, Vianex, Laboratoires Th\u00e9a, Cooper and research support from Laboratoires Th\u00e9a.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"This article does not contain any studies with animals performed by any of the authors.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Statment on the welfare of animals"}}]}}